Literature DB >> 22955844

Tumour immunology: Differing roles for MYD88 in carcinogenesis.

Ezzie Hutchinson.   

Abstract

Entities:  

Year:  2012        PMID： 22955844     DOI： 10.1038/nri3304

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  2 in total

1.  MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells.

Authors:  Atsuo Ochi; Andrew H Nguyen; Andrea S Bedrosian; Harry M Mushlin; Saman Zarbakhsh; Rocky Barilla; Constantinos P Zambirinis; Nina C Fallon; Adeel Rehman; Yuliya Pylayeva-Gupta; Sana Badar; Cristina H Hajdu; Alan B Frey; Dafna Bar-Sagi; George Miller
Journal:  J Exp Med       Date:  2012-08-20       Impact factor: 14.307

2.  IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis.

Authors:  Christophe Cataisson; Rosalba Salcedo; Shakeeb Hakim; B Andrea Moffitt; Lisa Wright; Ming Yi; Robert Stephens; Ren-Ming Dai; Lyudmila Lyakh; Dominik Schenten; H Stuart Yuspa; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2012-08-20       Impact factor: 14.307
  2 in total
  1 in total

1.  Quantifying immune-based counterselection of somatic mutations.

Authors:  Fan Yang; Dae-Kyum Kim; Hidewaki Nakagawa; Shuto Hayashi; Seiya Imoto; Lincoln Stein; Frederick P Roth
Journal:  PLoS Genet       Date:  2019-07-25       Impact factor: 5.917
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.